Modern Glioma Management

Name: Modern Glioma Management: Integrating Molecular Markers and New Targeted Therapies
Uploaded: 2025-12-02T15:24:00+00:00
Duration: 13 min 47 s
Description: Patrick Y. Wen, MD, Dana-Farber Cancer Institute, Boston, MA, discusses current standards of care for low- and high-grade gliomas, including the importance

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Neuro-Oncology Outlook: IDH-Mutant Glioma—Clinical Insights and Emerging Directions
Neuro-Oncology Outlook: IDH-Mutant Glioma—Clinical Insights and Emerging Directions
Neuro-oncology
Neuro-Oncology Outlook: IDH-Mutant Glioma—Clinical Insights and Emerging Directions
Tyler A. Lanman, MD
Tyler A. Lanman, MD
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Alzheimer Disease & Dementias
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Direct Neural Invasion: A Proposed Mechanism for Neurologic Symptoms Associated with Chronic Lymphocytic Leukemia with No Mass Lesions
Direct Neural Invasion: A Proposed Mechanism for Neurologic Symptoms Associated with Chronic Lymphocytic Leukemia with No Mass Lesions
Neuro-oncology
Direct Neural Invasion: A Proposed Mechanism for Neurologic Symptoms Associated with Chronic Lymphocytic Leukemia with No Mass Lesions
Enmanuel J. Perez, MD, PhD; Garrett Camps, BEng, MD
Enmanuel J. Perez, MD, PhD; Garrett Camps, BEng, MD
Care of Individuals with Neurofibromatosis Type 1 Amid an Evolving Paradigm of Therapeutic Development
Care of Individuals with Neurofibromatosis Type 1 Amid an Evolving Paradigm of Therapeutic Development
Neuro-oncology
Care of Individuals with Neurofibromatosis Type 1 Amid an Evolving Paradigm of Therapeutic Development
Alyssa Lucas, MD; Mina Lobbous, MD
Alyssa Lucas, MD; Mina Lobbous, MD